Treatment Decision Making in Relapsed/Refractory Multiple Myeloma
To address the complexities of relapsed/refractory multiple myeloma, a panel of experts reviews a clinical case and delivers a roadmap for potential treatment options.
Approaches to Bladder Cancer Treatment
As part of its Morning Rounds series, a panel of specialists dives into the latest bladder cancer treatments, analyzing how recent clinical trial results are influencing their approach.
Pembrolizumab Plus Chemo Improves Overall Survival in Resectable Gastric Cancer
Ibrutinib-Venetoclax Combo Elicits Durable Complete Responses in TP53+ MCL
Brentuximab Vedotin Triplet Provides Stronger Survival Signal vs R2 in R/R DLBCL
Durvalumab Plus Chemo Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer